 | SHIVOM (OMX)ICO  SHIVOM is medicine ecosystem will provide space for other healthcare and wellness providers such as clinics, genomic counselors, pharmaceuticals, research organizations, governments, patient-support groups, and insurance companies to add their apps and services. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
OpenWhat is SHIVOM
SHIVOM users will be able to get their genome sequenced and stored, and ecosystem will ofer an open web-marketplace for other providers to add their apps and services, alongside genomic data analytics and personalized medicine. Solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.
DetailsPre-sales: Apr 16, 2018 - Apr 27, 2018Public sales: May 03, 2018 - May 10, 2018 Token supply: 990000000 Soft cap: 15,000ETH Hard cap: 35,000,000 USD(fiat) Raised: 35,000,000 USD | Token infoTicker: OMXType: Utility-token Token standard: ERC-20 Token price in USD: 1 OMX = 0.108864 USD Token price in ETH: 1 Token = 0.000140 ETH Accepted currencies: ETH Token distribution: Founders - 14% Advisors - 10% Growth Pool - 20% Reserve - 20% Community - 3% Token Sale - 33% Funds allocation: Platform Development - 20% Operations - 11% Legal - 5% Sequencing PoC - 2% Marketing - 21% Data Storage - 6% Laboratories - 25% R&D - 10% |
SHIVOM Roadmap
Conceptualization healthcare ecosystem initiated.
Seed round of $250k finished.
Start of global roadshow.
Whitepaper released.
OmiX token sale starts.
Shivom foundation established. Foundation director and first steering committee members on board.
Partnership major crypto vc.
Partnership medical center. Collaboration with first of many large clinical centers.Project gaia started. Sequencing project in rural India commenced. Platform alpha release.
Partnership major data analytics firm. Co -development to connect Shivom platform with stat-of-the art data analytics pipeline. Pharma partner on board. Collaboration with Top 25 pharmaceutical company.
Web marketplace open.
Formation R&D unit. Official start of global not-forprofit pharmaceutical spin-of. Worldwide rollout of Shivom platform. Shivom services are available on a global scale on all continents.
First rare- disease subset. Set of large group of people sequenced with rare disease. First genomics service unit opens. First genomics counseling service unit opens.
Multi-omics integration. A.I. platform. Implementation of artificial intelligence, deep learning platform.
Project team
Advisors
Social media
